MediWound Ltd (NAS:MDWD)

$ 17.7 -0.13 (-0.73%) Market Cap: 190.98 Mil Enterprise Value: 153.28 Mil PE Ratio: 0 PB Ratio: 5.58 GF Score: 56/100

Q3 2024 Mediwound Ltd Earnings Call Transcript
Nov 26, 2024

$16.9 (-2.48%)

Earnings
Q2 2024 Mediwound Ltd Earnings Call Transcript
Aug 14, 2024

$17.47 (-4.06%)

Earnings
Q1 2024 Mediwound Ltd Earnings Call Transcript
May 29, 2024

$16.01 (-10.01%)

Earnings
Q4 2023 Mediwound Ltd Earnings Call Transcript
Mar 21, 2024

$15.95 (+2.11%)

Earnings
Q3 2023 Mediwound Ltd Earnings Call Transcript
Nov 21, 2023

$8.4 (-1.87%)

Earnings
Q2 2023 Mediwound Ltd Earnings Call Transcript
Aug 16, 2023

$8.92 (-1.54%)

Earnings
Q1 2023 Mediwound Ltd Earnings Call Transcript
May 30, 2023

$8.99 (-7.46%)

Earnings
Q4 2022 Mediwound Ltd Earnings Call Transcript
Mar 16, 2023

$10.65 (-4.57%)

Earnings
Q3 2022 Mediwound Ltd Earnings Call Transcript
Nov 15, 2022

$11.69 (+15.17%)

Earnings
Q2 2022 Mediwound Ltd Earnings Call Transcript
Aug 09, 2022

$12.39 (-1.67%)

Earnings
Mediwound Ltd KOL Event on EscharEx Transcript
Jul 12, 2022
Q1 2022 Mediwound Ltd Earnings Call Transcript
May 17, 2022

$12.39 (-6.35%)

Earnings
Q4 2021 Mediwound Ltd Earnings Call Transcript
Mar 17, 2022

$13.37 (-0.52%)

Earnings
Q3 2021 Mediwound Ltd Earnings Call Transcript
Nov 16, 2021

$22.05 (-7.35%)

Earnings
Q2 2021 Mediwound Ltd Earnings Call Transcript
Aug 10, 2021

$26.6 (-0.78%)

Earnings
Q1 2021 Mediwound Ltd Earnings Call Transcript
May 05, 2021

$29.61 (-9.62%)

Earnings
Mediwound Ltd Analyst Day Transcript
Mar 30, 2021
Q4 2020 Mediwound Ltd Earnings Call Transcript
Feb 25, 2021

$37.03 (-5.54%)

Earnings
Q3 2020 Mediwound Ltd Earnings Call Transcript
Nov 10, 2020

$26.88

Earnings
Q2 2020 Mediwound Ltd Earnings Call Transcript
Aug 06, 2020

$28.98 (+0.49%)

Earnings
Q1 2020 Mediwound Ltd Earnings Call Transcript
May 20, 2020

$13.84 (+0.89%)

Earnings
Q4 2019 Mediwound Ltd Earnings Call Transcript
Feb 25, 2020

$18.9 (-7.53%)

Earnings
Q3 2019 Mediwound Ltd Earnings Call Transcript
Nov 14, 2019

$21.49 (+7.72%)

Earnings
Q2 2019 Mediwound Ltd Earnings Call Transcript
Aug 13, 2019

$22.19 (-3.21%)

Earnings
Mediwound Ltd Corporate Analyst Meeting Transcript
Jul 22, 2019
Q1 2019 Mediwound Ltd Earnings Call Transcript
May 21, 2019

$29.19 (-3.70%)

Earnings
MediWound Ltd. - Special Call Transcript
May 07, 2019
Q4 2018 Mediwound Ltd Earnings Call Transcript
Mar 25, 2019

Earnings

MediWound Ltd. - Special Call Transcript

May 07, 2019 / 12:00PM GMT

Release Date Price: $33.39 (-10.67%)

Transcript

Operator

Good day, ladies and gentlemen, and welcome to the MediWound Ltd. Strategic Partnership Call. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conference, Jeremy Feffer, Investor Relations. Jeremy?

Jeremy Feffer

LifeSci Advisors, LLC - MD

Thank you, Nova, and good morning, everyone. Earlier today, MediWound issued a press release announcing that it has entered into an exclusive license and supply agreement with Vericel for commercial rights to NexoBrid in North America. You may access that release on the website under the Investors Relations tab. An investor deck is also available under the Investor tab.

With us today are Steve Wills, Active Chairman of the Board; and Sharon Malka, Chief Executive Officer. Following management's prepared remarks, we will open the call for Q&A.

Before we begin, I would like to remind everyone that statements made during this call, including the Q&A session, relating to MediWound's expected future performance, future

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.